logo
Select company
Select metric
$ -57.29MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
12
Sector
30
Industry
43
History
78
$ 1.84Close
$ 0.73 - $ 2.59 52-Week Range
Ticker Information

Ticker

STTK

Company Name

SHATTUCK LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SHATTUCK LABS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STTK - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 4.22M$ -61.51M$ -57.29M
3/31/2025$ 4.24M$ -70.61M$ -66.37M
12/31/2024$ 4.26M$ -75.41M$ -71.15M
9/30/2024$ 4.28M$ -74.42M$ -70.14M
6/30/2024$ 4.33M$ -85.28M$ -80.95M
3/31/2024$ 4.38M$ -85.08M$ -80.7M
12/31/2023$ 4.41M$ -87.3M$ -82.89M
9/30/2023$ 4.42M$ -95.02M$ -90.61M
6/30/2023$ 4.32M$ -92.12M$ -87.8M
3/31/2023$ 3.94M$ -98.14M$ -94.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SHATTUCK LABS INC's latest trailing twelve months (TTM) EBITDA stands at $ -35.98M.
  • Over the past 5 years, SHATTUCK LABS INC's average EBITDA has been $ -70.2M.
  • The median EBITDA for SHATTUCK LABS INC during this period was $ -68.25M
  • SHATTUCK LABS INC reached its highest EBITDA over the past 5 years at $ -35.98M.
  • The lowest EBITDA recorded by SHATTUCK LABS INC in the same timeframe $ -98.57M

SHATTUCK LABS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CAMP : CAMP4 THERAPEUTICS CORP $ -48.23MALGS : ALIGOS THERAPEUTICS INC $ -58.76MNRXS : NEURAXIS INC $ -7.03MPLUR : PLURI INC $ -21.19MDYAI : DYADIC INTERNATIONAL INC $ -5.09MRANI : RANI THERAPEUTICS HOLDINGS INC $ -22.1MTRAW : TRAWS PHARMA INC $ 87.92MPYXS : PYXIS ONCOLOGY INC $ -95.04MIGC : IGC PHARMA INC $ -5.75MCLSD : CLEARSIDE BIOMEDICAL INC $ -26.67M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for SHATTUCK LABS INC is calculated as follows: EBIT [ $ -36.6M ] + DepAmor [ $ 618K ]
(=) EBITDA [ $ -35.98M ]

STTK - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -98.57M

Minimum

Dec 31, 2022

$ -35.98M

Maximum

Dec 31, 2020

$ -70.2M

Average

$ -68.25M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M